Oscor Inc. Issues Voluntary Worldwide Recall of Destino Twist Steerable Guiding Sheath Due to the Risk of the Device Hub Cap and Seal on the Proximal End of the Device Handle Detachment During Use

Summary Company Announcement Date: January 12, 2022 FDA Publish Date: January 12, 2022 Product Type: Medical Devices Reason for Announcement: Recall Reason Description Hub cap and seal on the proximal end of the device handle may detach during use Company Name: Oscor Inc. Brand Name: Brand Name(s) Product Description: Product Description Destino Twist 14F model…

Buprenorphine: Drug Safety Communication – FDA warns about dental problems with buprenorphine medicines dissolved in the mouth to treat opioid use disorder and pain

[Posted 01/12/2022] AUDIENCE: Dentistry, Anesthesiology, Patient, Health Professional, Pharmacy ISSUE:  The FDA is warning that dental problems have been reported with medicines containing buprenorphine that are dissolved in the mouth.  The dental problems, including tooth decay, cavities, oral infections, and loss of teeth, can be serious and have been reported even in patients with no history of…

2022 Safety Communications

The FDA posts Medical Device Safety Communications to describe the FDA’s current analysis of an issue and contain specific regulatory approaches and clinical recommendations for patient management. 2022 Safety Communications Content current as of: 01/13/2022 Regulated Product(s) Article source: http://www.fda.gov/medical-devices/safety-communications/2022-safety-communications

Lohxa LLC Issues Voluntary Nationwide Recall of Senna Syrup 8.8mg/5mL Due to Microbial Contamination

Summary Company Announcement Date: January 11, 2022 FDA Publish Date: January 12, 2022 Product Type: Drugs Reason for Announcement: Recall Reason Description Potential microbial contamination Company Name: Lohxa LLC Brand Name: Brand Name(s) Product Description: Product Description Senna Syrup 5mL Company Announcement FOR IMMEDIATE RELEASE – 01/11/2022 – Worcester, MA. Lohxa LLC is voluntarily recalling…

Stop Using LuSys Laboratories COVID-19 Tests: FDA Safety Communication

Date Issued: January 11, 2022 The U.S. Food and Drug Administration (FDA) is warning people to stop using the LuSys Laboratories COVID-19 Antigen Test (Nasal/Saliva) and the LuSys Laboratories COVID-19 IgG/IgM Antibody Test. The performance of these tests has not been adequately established and the FDA believes there is likely a high risk of false…

2022 Medical Device Recalls

The list below contains recalls that were issued in 2022. 2022 Medical Device Recalls Content current as of: 01/03/2022 Regulated Product(s) Article source: http://www.fda.gov/medical-devices/medical-device-recalls/2022-medical-device-recalls

Taro Pharmaceuticals U.S.A. Issues Voluntary Nationwide Recall of Clobetasol Propionate Ointment USP, 0.05%, 60 g Tubes, Lot AC13786 Due to Microbial Contamination

Summary Company Announcement Date: December 27, 2021 FDA Publish Date: December 30, 2021 Product Type: Drugs Reason for Announcement: Recall Reason Description Presence of Ralstonia pickettii bacteria Company Name: Taro Pharmaceuticals USA, Inc. Brand Name: Brand Name(s) Product Description: Product Description Clobetasol Propionate Company Announcement FOR IMMEDIATE RELEASE – Hawthorne, NY, December 27, 2021 ─…